Chloride channel protein (ClC)-6a and ClC-6c, a kidney-specific splice variant with a truncated C-terminus, are proteins that belong structurally to the family of voltage-dependent chloride channels. Attempts to characterize functionally ClC-6a or ClC6c in Xenopus oocytes have so far been negative. Similarly, expression of both ClC-6 isoforms in mammalian cells failed to provide functional information. One possible explanation of these negative results is that ClC-6 is an intracellular chloride channel rather than being located in the plasma membrane. We therefore studied the subcellular location of ClC-6 isoforms by transiently transfecting COS and CHO cells with epitope-tagged versions of ClC-6a and ClC-6c. Confocal imaging of transfected
INTRODUCTION
The ClC chloride channel family forms a group of structurallyrelated membrane proteins members of which have been identified in bacteria, plants, yeast, fish and mammals [1, 2] . Mammals possess at least nine different ClC genes (ClC-1 to -7 and ClC-K1 and -K2) and the number of ClC isoforms is further increased by alternative splicing [3] [4] [5] . All ClC proteins, with the exception of some of the splice variants, have a common structure with an even number (10 or 12) of transmembrane domains and with intracellular N-and C-termini [2, 6, 7] . There is conclusive experimental evidence that some ClC members form plasmamembrane located chloride channels [1, 2] . For example, expression of ClC-0 in Xenopus oocytes or incorporation of purified ClC-0 into lipid bilayers generates a voltage-dependent chloride current with double-barrelled gating kinetics [8, 9] . The functional channel complex is composed of a homodimer with two distinct pores, each of which is independently operated by a voltagedependent fast gate [10, 11] . Furthermore, the permeating anion (and not an intrinsic structural element) serves as the voltagesensor of the fast gate [12, 13] . Thus ClC-0 represents a new paradigm for voltage-dependent ion channels that fundamentally differs from the voltage-dependent cation channels. Similarly, expression of ClC-1 in Xenopus oocytes, insect cells or mammalian cells has clearly established that ClC-1 is a plasmamembrane chloride channel that stabilizes the membrane potential in skeletal muscle [14] [15] [16] . The detailed biophysical and functional characterization of ClC-0 and ClC-1 contrasts sharply with the lack of knowledge for ClC-6. A major obstacle in this regard is that injection of Xenopus oocytes with ClC-6a RNA had either no effect [17] or resulted in the activation of an endogenous chloride conductance [18] . Therefore although ClC-6a structurally belongs to a family of plasma-membrane Abbreviations used : ClC, chloride channel protein ; I Cln , nucleotide-sensitive chloride current ; SERCA2b, sarco/endoplasmic-reticulum Ca 2 + pump ; CD2, T-lymphocyte cell-surface antigen ; CHO, Chinese hamster ovary ; TRITC, tetramethylrhodamine isothiocyanate. 1 To whom correspondence should be addressed.
cells revealed for both ClC-6 isoforms an intracellular distribution pattern that clearly differed from the peripheral location of CD2, a plasma-membrane glycoprotein. Furthermore, dual-labelling experiments of COS cells co-transfected with ClC-6a or -6c and the sarco\endoplasmic-reticulum Ca# + pump (SERCA2b) indicated that the ClC-6 isoforms co-localized with the SERCA2b Ca# + pump. Thus ClC-6a and ClC-6c are intracellular membrane proteins, most likely residing in the endoplasmic reticulum. In view of their structural similarity to proven chloride channels, ClC-6 isoforms are molecular candidates for intracellular chloride channels.
chloride channels, it has not yet been possible to ascertain its proper function. We have recently shown that ClC-6 can be alternatively spliced resulting in four distinct isoforms, ClC-6a to ClC-6d [4] . The ClC-6a isoform is identical to the ClC-6 protein originally described [17] . It has a canonical ClC structure with 10-12 predicted transmembrane domains. In contrast, ClC-6b, -6c and -6d are truncated at their C-terminus and they contain maximally 4 (ClC-6b and ClC-6d) or 7 (ClC-6c) transmembrane domains. ClC-6a and ClC-6c are the most abundant isoforms with ClC-6a being ubiquitously expressed and ClC-6c being limited to the kidney [4, 17] . We now demonstrate that ClC-6a and ClC-6c escape functional characterization in Xenopus oocytes and in mammalian cells because of their intracellular location. Indeed, ClC-6a and -6c co-localize with the sarco\endoplasmic-reticulum Ca# + pump (SERCA2b) when transiently transfected in COS cells.
EXPERIMENTAL Vector construction
A c-Myc epitope (amino acids EQKLISEEDL ; see [19] ) was inserted at the N-terminus of a human ClC-6c cDNA clone [4] via PCR mutagenesis. A BamHI-SalI restriction fragment containing the cMycClC6c open reading frame was subcloned into the mammalian expression vector pCIneo (Promega) resulting in the pCIneo\cMycClC6c vector. c-Myc epitope tagging of human ClC-6a was performed by replacing the ClC-6c-specific XbaIHindIII fragment in pCIneo\cMycClC6c with the ClC-6a-specific XbaI-HindIII fragment generating the pCIneo\cMycClC6a vector. The c-Myc epitope tag was inserted at the C-terminus of human ClC-6a and -6c via PCR mutagenesis. Subcloning into pCIneo of BamHI-HindIII restriction fragments containing the C-terminal-tagged open reading frames resulted in the pCIneo\ ClC6acMyc and the pCIneo\ClC6ccMyc vectors. The pSV57\ SERCA2b and pKG5\CD2 vectors were kindly given by F. Wuytack (Katholieke Universiteit, Leuven, Belgium) and N. Barclay (University of Oxford, Oxford, U.K.) respectively.
cDNA fragments encoding either ClC-6a or ClC-6c were inserted in the bicistronic GFP-expression vector pCIneo\IRES-GFP [20] by blunt-end ligation. To this end, the pCIneo\IRES-GFP vector was digested with EcoRI and blunt ended with T4 DNA polymerase. The ClC-6a and ClC-6c fragments were bluntended BamHI\HindIII restriction fragments of pBS\ClC-6a and pBS\ClC-6c [4] respectively. The c-Myc epitope was inserted at the N-terminus of a rat ClC-1 cDNA clone (a gift from T. J. Jentsch, Hamburg University, Germany) via PCR-mutagenesis. A blunt-ended restriction fragment containing the cMycClCl open reading frame was cloned in the EcoRI-digested and bluntended pCIneo\IRES-GFP vector resulting in the pCIneo\IRES-GFP\cMycClCl.
Transient transfection of mammalian cells
COS cells and Chinese hamster ovary (CHO) cells were transiently transfected using the polycationic liposome Lipofect AMINE4 (Life Technologies) following the manufacturer's instructions. In short, exponentially-growing cells were seeded the day before transfection at a density of 15 000 cells\cm# in tissue-culture dishes (35-mm diam.). At 50-80 % confluency, cells were incubated for 6 h with a transfection cocktail containing 2 µg DNA and 4 µl LipofectAMINE4 reagent per 35-mm dish. For co-transfection, we used 1n5 µg DNA of each vector (1 : 1 ratio) and 6 µl LipofectAMINE4 per 35-mm dish. Cells were transferred after 24 h to gelatin-coated 2-well coverslip culture chambers (Lab Tek, Nunc Inc.) and grown for another 24 h before the start of the immunostaining procedure. For patchclamp analysis, cells were transfected in 35-mm dishes, transferred to coverslips after 24 h and electrophysiological measurements were started 48 h after transfection. Alternatively, cells were transfected by the Superfect Transfection protocol (Qiagen), using 2n5 µg DNA and 12 µl Superfect reagent per 35-mm dish.
Current measurements in COS cells
For current recordings, fluorescent cells were visualized in a patch-clamp set up (EPC7) containing a Zeiss Axiovert 100 microscope, a Xenon light source and epifluorescence optics (Zeiss XBO 75 and Zeiss-EPI unit fluorescence condenser). A band-pass filter (Zeiss filter set 9,487909 ; BP 450-490) was used for excitation. Light was transmitted to the cells via a dichroic mirror (Zeiss FT 510). Emitted light passed through a 520-nm long-pass filter (Zeiss, LP 520) and was detected visually. Wholecell membrane currents were monitored with an EPC7 patch clamp amplifier using the following voltage protocol : from a holding potential of k30 mV cells were pre-pulsed to j80 mV for 100 ms, after which voltage steps of 400 ms were applied from k140 to j80 mV in j20-mV increments. This was followed by a 50 ms after pulse to k100 mV. Currents were sampled at 1 ms intervals. Sampling and stimulation were controlled via the pClamp 5.7.1. software (Axon Instruments, Foster City, CA, U.S.A.). All experiments were performed at room temperature. The extracellular solution was a modified Krebs solution containing 150 mM NaCl, 6 mM KCl, 1n5 mM CaCl # , 10 mM Hepes and 10 mM glucose, adjusted to pH 7n4 with NaOH. In some experiments, CdCl # was added to the bath solution at a concentration of 1 mM. The osmolarity of the extracellular solutions, measured with a vapour osmometer (Wescor 5500, Schlag, Gladbach, Germany), was 320p5 mosmol\l. Pipette solutions contained 40 mM KCl, 100 mM K-aspartate, 4 mM Na # ATP, 1 mM MgCl # , 0n1 mM EGTA, 10 mM Hepes, adjusted to pH 7n2 with KOH.
Confocal immunofluorescence study of ClC-6 localization in transiently transfected cells
Cells were fixed in PBS containing 3 % (w\v) paraformaldehyde for 15 min, permeabilized with 0n5 % (v\v) Triton X-100 for 10 min and blocked with 20 % (v\v) goat serum in PBS for 1 h. They were then incubated for 16-72 h at 4 mC with primary antibodies : c-Myc 9E10 (Santa Cruz) for c-Myc epitope-tagged versions of ClC-6a and ClC-6c ; IID8 for SERCA2b ; and Ox34 for CD2. Thereafter, the cells were treated with FITC-conjugated goat anti-mouse IgG (Sigma ImmunoChemicals) at room temperature for 1 h. Control reactions were performed by incubating transfected cells with the secondary antibodies only and by processing mock-transfected cells with primary and secondary antibodies. Cells were imaged using a Bio-Rad MRC 1000 UV confocal laser-scanning microscope with a 40i oil-immersion objective and a Kalman filter averaging 2 to 5 frames. Both confocal (iris confocal aperture 0n7-3n5 mm) and non-confocal images (768i512 lines) were stored.
Co-localization of ClC-6a or -6c and SERCA2b was studied in co-transfected COS cells (see above). SERCA2b expression was detected with polyclonal affinity-purified primary antibodies and tetramethylrhodamine isothiocyanate (TRITC )-labelled antirabbit IgG (Sigma ImmunoChemicals) as secondary antibodies. cMyc\ClC-6a or -6c was detected with the 9E10 monoclonal antibody and FITC-labelled secondary antibodies. Two separate epi-detectors filtering FITC and TRITC emission signals allowed simultaneous dual imaging of cMyc\ClC-6 and SERCA2b.
RESULTS

Functional characterization of COS cells transiently transfected with ClC-6a or ClC-6c
Brandt and Jentsch [17] reported that attempts to express human ClC-6a functionally in Xenopus oocytes were without success. In our hands, expression of ClC-6a or ClC-6c in Xenopus oocytes activated an endogenous nucleotide-sensitive chloride current (I Cln ) provided that the oocytes were incubated at a higher temperature (24 mC for 2 h or 37 mC for 30 min) before the electrophysiological analysis at room temperature (results not shown and [18] ). The I Cln is identical with the chloride current observed after expression of mammalian pI Cln in Xenopus oocytes [18, 21, 22] . It has thus been concluded that ClC-6a and ClC-6c can induce expression of an endogenous chloride channel in oocytes.
As an alternative to expression in Xenopus oocytes we tried transient transfection of ClC-6 isoforms in a mammalian cell line (COS7) (Figure 1 ). ClC-6a and ClC-6c were subcloned in a bicistronic GFP-expression vector (pCIneo\IRES-GFP) which allows identification of channel-expressing cells using green fluorescence [20] . Electrophysiological analysis of all green cells transfected with either ClC-6a (n l 11) or ClC-6c (n l 9) was negative and the recorded currents did not differ significantly from the control currents obtained in non-fluorescent cells (n l 11) (Figures 1A and 1B) . This contrasted sharply with a previous study in which RCK1, a Kv1n1 K + channel, was transiently expressed in COS cells using the pCIneo\IRES-GFP vector. After transfection with RCK1 every green cell tested expressed the typical K + current [20] . As an additional positive control rat ClC-1 (containing an N-terminal c-Myc epitope) was transfected into COS cells using the pCIneo\IRES-GFP vector. The membrane resistance of all green cells was low (15n2p2n2 MOhm, n l 7) most likely because of the overexpression of ClC-1 channels. With an access resistance of 7n6p0n5 MOhm (n l 21) it was thus impossible to clamp the green fluorescent cells. We, therefore, partially reduced the overexpressed ClC-1 chloride current by supplementing the extracellular solution with 1 mM Cd# + , which induces approx. 50 % block of ClC-1 currents [23, 24] . Under these conditions we were able to measure a voltage-dependent current in green cells which reversed at k20 mV and which rapidly deactivated upon hyperpolarisation, similar to that described for ClC-1 [16] (Figures 1C and 1D ). These currents were never observed in dark cells or in nontransfected cells. Thus although transient transfection of ClC-1 yielded typical membrane currents, cells transfected with ClC-6a or ClC-6c remained negative.
Morphological evidence for an intracellular location of ClC-6 proteins
To further investigate why heterologous expression of ClC-6a and ClC-6c in COS cells failed to provide functional information, the expression of ClC-6 isoforms was checked in transiently transfected COS cells by confocal immunofluorescence microscopy (Figures 2 A-D) . To facilitate detection of transfected proteins, ClC-6a and ClC-6c proteins were tagged with an N-terminal c-Myc epitope. Confocal images of cells transfected with ClC-6a and ClC-6c showed that the strongest fluorescence was concentrated around the nucleus and that the intensity of the signal decreased at the periphery of the cell (Figures 2A and 2B) . No fluorescent signals were observed in transfected cells when the primary anti-c-Myc antibody was omitted during the staining procedure or when mock-transfected cells were processed with primary and secondary antibodies (results not shown). The distribution pattern of the ClC-6 isoforms was then compared with that of SERCA2b, the endoplasmic reticulum Ca# + pump of non-muscle cells [25] and of CD2, a T-lymphocyte plasmamembrane glycoprotein [26] . Interestingly, the SERCA2b distribution pattern ( Figure 2C ) was virtually identical to that of ClC-6a and ClC-6c. In contrast, the CD2 pattern clearly differed in that staining for CD2 resulted in fluorescent signals that were most intense at the cell periphery ( Figure 2D) .
To exclude the possibility that the intracellular location of ClC-6 isoforms was an artefactual observation, various control experiments were performed. First, we tested whether the modified N-terminus of the c-Myc tagged ClC-6 isoforms might interfere with the delivery of newly synthesized ClC-6 proteins to the plasma membrane. To this end, the c-Myc epitope was inserted at the C-terminus of the ClC-6 isoforms and their distribution after transient transfection in COS cells was examined ( Figures 2E and 2F ). This revealed, for both isoforms, a distribution pattern that was completely identical with that of ClC-6 proteins containing the N-terminal epitope tag. Thus the modified N-terminus cannot account for the intracellular location of the ClC-6 isoforms. Secondly, we checked whether the intracellular distribution might be an artefact of the expression system. COS cells express the SV40 large T antigen, which permits episomal replication of expression vectors such as pCIneo that contain the SV40 ori sequence [27] . To avoid plasmid amplification, we transfected the N-terminal-tagged ClC-6 isoforms in CHO cells, which do not express the SV40 large T antigen. Furthermore, CHO cells have been used successfully to express ion channels at the plasma membrane [28] [29] [30] [31] . When expressed in CHO cells, both ClC-6a and ClC-6c displayed an intracellular distribution pattern identical with that in COS cells (Figures 2G and 2H) . The strong intracellular perinuclear staining was virtually identical to that of SERCA2b ( Figure 2I ) and clearly differed from the peripheral pattern of CD2 ( Figure 2J ). Thus the overexpression system in COS cells is not responsible for the intracellular location. Finally, we tested whether the cMyc epitope prevented plasma-membrane proteins from reaching their normal location in COS cells. Control experiments were performed by transiently transfecting COS cells with rat ClC-1 containing an N-terminal c-Myc epitope. As shown in Figure 1 (C and D), COS cells transfected with epitope-tagged ClC-1 acquired a voltage-dependent plasma-membrane current indicating that the c-Myc-tagged ClC-1 had reached the plasma membrane. In view of these control experiments we concluded that the intracellular location of ClC-6 isoforms cannot be attributed to artefacts arising from modifications to the Nterminus, the expression system or the c-Myc epitope.
Co-localization of ClC-6a/6c and SERCA2b
Finally, we compared the distribution pattern of ClC-6 isoforms and SERCA2b by double-labelling of co-transfected COS cells. ClC-6a and ClC-6c were visualized using FITC-labelled secondary antibodies, whereas the SERCA2b signal was generated via TRITC-labelled secondary antibodies. Cells that expressed both ClC-6 and SERCA2b were subjected to confocal analysis (Figure 3) . Within the same cell there was basically no difference between the ClC-6 and the SERCA2b distribution pattern indicating that both proteins co-localize. The specificity of ClC-6 and SERCA2b detection was checked by omitting either the anti-c-Myc antibodies or the anti-SERCA2b antibodies. In the former case, no FITC signals were detected and no TRITC signals were present in the latter situation (results not shown). Thus these data indicate that ClC-6a and ClC-6c are intracellular membrane proteins that most likely reside in the endoplasmic reticulum.
Figure 2 Intracellular location of ClC-6 isoforms in transiently transfected COS and CHO cells
Confocal-immunofluorescence detection of ClC-6a, ClC-6c, SERCA2b and CD2 in transiently transfected COS (A-F) and CHO (G-J) cells. Tagging of ClC-6 isoforms with a c-Myc epitope allowed detection of ClC-6 isoforms with the monoclonal c-Myc 9E10 antibody. SERCA2b and CD2 were detected with monoclonal antibodies IID8 and Ox34 respectively. The specificity of the signals was verified by omitting the primary antibodies and incubating the cells with only the secondary FITC-conjugated antibodies and by processing mock-transfected cells with primary and secondary antibodies (results not shown). In COS cells, N-terminal epitope-tagged ClC-6a (A) and ClC-6c (B) were located intracellularly with a distribution pattern virtually identical to that of SERCA2b (C), an endoplasmic-reticulum membrane protein. This pattern is in sharp contrast with that of CD2 (D), a plasma-membrane protein. Both ClC-6 isoforms were tagged also with a C-terminal c-Myc epitope. As shown in (E) (F) ClC-6a and ClC-6c, displayed an identical intracellular distribution pattern to the N-terminal tagged versions of ClC-6. To exclude the possibility that the intracellular location of ClC-6 isoforms was an artefact of overexpression in COS cells, we studied their subcellular distribution pattern when expressed in CHO cells (G-J). The intracellular staining pattern of N-terminal-tagged ClC-6a (G) and ClC-6c (H) is virtually identical to that of SERCA2b (I) and clearly different from that of CD2 (J). The colour scale (see vertical bar in B and H) ranges from blue (background signal) to white (saturating signal). Scale bars are shown in each panel.
DISCUSSION
The observation that ClC-6a and ClC-6c are intracellular proteins that most likely reside in the endoplasmic reticulum provides an explanation as to why their expression in Xenopus oocytes and in mammalian cells has failed to elucidate their function. Indeed, using the voltage-clamp technique one can readily access ion channels that are present in the plasma membrane, but not intracellularly located channels.
The structural similarity of ClC-6 isoforms to well-established chloride channels such as ClC-0 and ClC-1 is compatible with their being anion channels. It is therefore possible, but not yet proven, that ClC-6a and possibly ClC-6c represent a new class of intracellular chloride (or anion) channels. Intracellular anion channels, other than the mitochondrial porins [32] , have been reported (for a review, see [33] ). For example, the sarcoplasmic reticulum in skeletal muscle and cardiac muscle contains anionselective pathways which have been studied by fusing sarcoplasmic-reticulum vesicles with lipid bilayers [34] [35] [36] . Similar techniques have permitted the identification of intracellular anion channels in non-excitable cells [37] . A possible function for the sarco\endoplasmic-reticulum-located chloride channels is to dissipate the electrical gradient that is created by the unidirectional movement of Ca# + (release or uptake) across the sarco\endoplasmic-reticulum membrane. Furthermore, it has been postulated that intracellular chloride channels play a permissive role in the acidification of Golgi vesicles, endosomes and lysosomes by dissipating the membrane potential created by the unidirectional transport of H + into the organellar lumen [33] .
The molecular identification of intracellular anion channels, except for the porins, is still incomplete. Because of its presence in endosomes it is possible that the cystic fibrosis transmembrane conductance regulator functions not only as a cAMP-regulated plasma-membrane chloride channel but also as an intracellular chloride channel involved in organellar acidification [38, 39] . Furthermore, there is evidence that two structurally related proteins, p64, a 64 kDa microsomal protein, and NCC27, a 27 kDa protein present in the nuclear envelope, form intracellular chloride channels or that they are regulators thereof [40] [41] [42] . Finally, there is growing evidence for ClC proteins as intracellular anion channels. Indeed, our results are consistent with an endoplasmic location for ClC-6 isoforms. Also, immunofluorescence imaging of pancreatic acinar cells showed ClC-2 protein in secretory vesicles close to the apical pole [43] . Furthermore, plant ClC isoforms, when expressed in yeast as well as the endogenous yeast ClC protein, are targeted to intracellular compartments [44] . However, caution must be exercised as functional proof of chloride-channel activity is still lacking for the ClC-6 isoforms as well as for the plant and yeast ClC proteins. Therefore further functions are required before these ClC proteins can be unambiguously classified as intracellular chloride channels.
Figure 3 Co-localization of ClC-6 isoforms with SERCA2b in transfected COS cells
Localization of cMyc/ClC-6 isoforms and the SERCA2b Ca 2 + pump was analysed in co-transfected COS cells by simultaneous dual confocal immunofluorescence. ClC-6 isoforms were visualized using FITC-labelled secondary antibodies, whereas the SERCA2b signal was generated via TRITC-labelled secondary antibodies. The specificity of the signals was first checked by omitting either the anti-c-Myc antibodies or the anti-SERCA2b antibodies (results not shown). 
